Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Marinobufagenin as a Target for DIGIBIND in Preeclampsia

This study has been completed.
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Institute on Aging (NIA) ) Identifier:
First received: April 1, 2011
Last updated: October 23, 2014
Last verified: July 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: July 2014
  Estimated Primary Completion Date: No date given